Abstract:BACKGROUND: The prognostic assessment of patients after surgical resection of gastric cancer (GC) patients is critical. However, the role of the circadian clock gene NPAS2 expression in GC remains unknown.AIM: To explore the relationship between NPAS2 and the survival prognosis of GC patients and clarify its role in evaluating GC prognosis.METHODS: The tumor tissues and clinical data of 101 patients with GC were collected retrospectively. Immunohistochemical staining (IHC) was used to detect the expression of NPAS2 protein in GC and adjacent tissues. Univariate and multivariate Cox regression analysis was used to determine the independent prognostic factors of GC, and a nomogram prediction model was established. The receiver operating characteristic (ROC) curve, the ROC area under the curve, the calibration curve, and C-index were used to evaluate the predictive effectiveness of the model. Kaplan Meier analysis was used to compare the risk stratification of subgroups according to the median score in the nomogram model of each patient.RESULTS: Microarray IHC analysis showed that the positive rate of NPAS2 protein expression in GC tissues was 65.35%, which was significantly higher than 30.69% in adjacent tissues. The high expression of NPAS2 was correlated with tumor-node-metastasis (TNM) stage (P < 0.05), pN stage (P < 0.05), metastasis (P < 0.05), venous invasion (P < 0.05), lymphatic invasion (P < 0.05), and lymph node positive (P < 0.05) of GC. Kaplan Meier survival analysis showed that the 3-year overall survival (OS) of patients with high NPAS2 expression was significantly shortened (P < 0.0001). Univariate and multivariate COX regression analysis showed that TNM stage (P = 0.009), metastasis (P = 0.009), and NPAS2 expression (P = 0.020) were independent prognostic factors of OS in GC patients for 3 years. The nomogram prediction model based on independent prognostic factors has a C-Index of 0.740 (95%CI: 0.713-0.767). Furthermore, subgroup analysis showed that the 3-year OS time of the high-risk group was significantly lower than that of the low-risk group (P < 0.0001).CONCLUSION: NPAS2 is highly expressed in GC tissues and is closely related to worse OS in patients. Therefore, the evaluation of NPAS2 expression may be a potential marker for GC prognosis evaluation. Notably, the nomogram model based on NPAS2 can improve the accuracy of GC prognosis prediction and assist clinicians in postoperative patient management and decision-making.

Overexpression of TC2N is Associated with Poor Prognosis in Gastric Cancer.

Gene expression analyses identify a relationship between stanniocalcin 2 and the malignant behavior of colorectal cancer.

Polypeptide N -acetylgalactosaminyltransferase-6 expression in gastric cancer.

TC2N: A Novel Vital Oncogene or Tumor Suppressor Gene In Cancers

CtBP2 Overexpression Promotes Tumor Cell Proliferation and Invasion in Gastric Cancer and is Associated with Poor Prognosis

Cystatin 2 leads to a worse prognosis in patients with gastric cancer

Identification Oftyrobpandc1qbas Two Novel Key Genes with Prognostic Value in Gastric Cancer by Network Analysis

Correlation Between Trop2 and Amphiregulin Coexpression and Overall Survival in Gastric Cancer.

Long Non-Coding RNA CCAT2 Promotes Gastric Cancer Proliferation and Invasion by Regulating the E-cadherin and LATS2.

TC2N Promotes Cell Proliferation and Metastasis in Hepatocellular Carcinoma by Targeting the Wnt/β-Catenin Signaling Pathway

Overexpression of FNDC 1 in Gastric Cancer and Its Prognostic Significance

Upregulation of OTX2-AS1 is Associated With Immune Infiltration and Predicts Prognosis of Gastric Cancer

High Level of TXNDC9 Predicts Poor Prognosis and Contributes to the NF-κB-regulated Metastatic Potential in Gastric Cancer.

Overexpression of CPXM2 Predicts an Unfavorable Prognosis and Promotes the Proliferation and Migration of Gastric Cancer

High Expression Of Tumor Necrosis Factor Receptor-Associated Factor 2 Promotes Tumor Metastasis And Is Associated With Unfavorable Prognosis In Gastric Cancer

High expression of the circadian clock gene NPAS2 is associated with progression and poor prognosis of gastric cancer: A single-center study

KIF2A Overexpression and Its Association with Clinicopathologic Characteristics and Poor Prognoses in Patients with Gastric Cancer

GCNT4 is Associated with Prognosis and Suppress Cell Proliferation in Gastric Cancer

High Intratumoral Expression of Tetranectin Associates with Poor Prognosis of Patients with Gastric Cancer after Gastrectomy.

GCN2 is a potential prognostic biomarker for human papillary renal cell carcinoma.

Characterization Of The Prognostic Values Of The Ndrg Family In Gastric Cancer